Aurobindo Pharma turns corner with Q2 profit at Rs 222.3 cr

Aurobindo Pharma has turned profitable in the second quarter by reporting a consolidated net profit of Rs 222.3 crore as against a loss of Rs 80 crore in the corresponding quarter of last fiscal, helped by forex gain.

Consolidated net sales rose 41 percent to Rs 1,481 crore from Rs 1,051 crore during the same period.

Healthcare firm has posted a foreign exchange gain of Rs 117.7 crore in the three months period ended September 2012 as against loss Rs 185.4 crore in a year ago period.

At 15:12 hours IST, the stock fell 3.9 percent to Rs 171.50 amid high volumes on the Bombay Stock Exchange after hitting a 52-week high of Rs 181.30.

Source: www.moneycontrol.com

Thanks,

Gaurav Agarwal

Head Dealer

DENIP Consultants Pvt Ltd